MilliporeSigma’s AAW™ Workstation Announcement The Canadian and US life science business, MilliporeSigma of Darmstadt, Merck KGaA, and Germany, as a global science and technology company, has introduced the AAW automated assay workstation. It is a solution for Opentrons. Opentrons ...
Lily’s New Formulation for Active CD Received Approval Announcement Eli Lily Canada Inc. received approval from Health Canada for Omvoh® (mirikizumab) for CD. It will be available soon for Canadian patients. This drug is an interleukin-23p19 antagonist used for the treatment of adult...
Time to Appreciate Women-led Biotech: Know More About the Leaders in Biotech Industry Accomplishment Last year's record shows that most of the standard acquisitions consist of women-led biotech valuable contributions to the biotech’s growth. The biopharma is strengthened and positioned h...
Akeso Enrolled First Patient for MCRc Akeso Inc. has enrolled its first patient in the registration phase 3 clinical trial AK112-312/HARMONi-GI6 of ivonescimab for its primary treatment of advanced metastatic colorectal cancer (mCRC). The phase 3 trial is a center for the company to achieve pri...
Kraig’s New Addition to the Healthcare Market Announcement Kraig Biocraft Laboratories Inc., a global leader in spider silk technology, has initiated a second parallel production facility, the quick introduction of a new diapausing system, and three new advanced spider silk strains for p...
The ViiV’s Study Indicates the Importance of Choosing Suitable Drugs Announcement ViiV Healthcare, the expert specialist HIV company majorly owned by GSK, along with Shionogi and Pfizer as shareholders, introduced data from its phase 3b volition study, which elaborates that around 89% (n...
Zimmer Biomet to Acquire Monogram Technologies Announcement Zimmer Biomet Holdings, Inc. a popular medical technology and Monogram Technologies, a known orthopedic robotics company, have signed an agreement to acquire outstanding shares of stock of monogram to receive an upfront payment of $4....
Acadia’s R&D Day and Upgradation New Products and Strong R&D Acadia Pharmaceuticals, in its 32 years of business and has currently organized its first R&D day, predicting annual sales of around $12 billion from its investigational chain. Daybue for Rett syndrome and Nuplazid ...
CEL-SCI’s Agreement Approach to a Saudi Arabian Pharma Company Announcement The CEL-SCI corporation (NYSE American CVM) has approached an agreement with a known Saudi Arabian premier healthcare and pharmaceutical company for a strategic partnership that includes commercial and regulatory a...
Nutcracker and Elegen’s Pilot Program Announcement The nutcracker therapeutics a RNA design and manufacturer and Elegen, a DNA manufacturer are introducing a pilot program to describe the company’s first ever full synthetic, cell-free manufacturing platform for RNA-powered personaliz...
‘Weight loss medication’ a New Trend in the Healthcare Market Announcement At the American Diabetes Association’s annual meeting, the need for new weight-loss medicines, primarily for muscle preservation and showing fewer side effects, was the center of concern. The topic enter...
Adopting Precision Diagnostics to Shape the Future of Oncology Therapies A Step Towards the Future of Advanced Therapies The AI-based analysis and digital imaging are believed to be advanced precision oncology therapies for the next generation to achieve potential and access to all patients. The...
Pfizer and Astellas' Positive Results Mark a Significant Improvement Image Credits: The Astellas US Newsroom Announcement Pfizer Inc. and Astellas Pharma Inc. proved their potential with the positive results directly from the overall survival (OS) analysis from its phase 3 study of EMBARK. A st...
Max Healthcare is Set to Flourish in the Healthcare Industry Image Credits: The Financial Express Efforts The hospital chain is expanding and focusing on growth in the Delhi-NCR region. The region is experiencing excellent growth in margins and ARPOB, and occupancy, which reflects the early day...
Novartis and Pan-Canadian’s Partnership has Finalized Negotiations Announcement Novartis Pharmaceuticals Canada Inc. finally confirms its partnership with Pan-Canadian Pharmaceutical by settling down with an effective negotiation on (Pcpa) public reimbursement of Cosentyx (secukinumab) for...
Pelthos Introduces New Medicine in the Healthcare Market Image Credits: eMPR Announcement Ligand Pharmaceuticals Incorporated partner Pelthos Therapeutics Inc has commercially introduced ZELSUVMI (berdazimer) topical gel 10.3%, which is an FDA-approved (at-home treatment) for molluscum contagio...
Connect Biopharma’s Partner Company to Submit its New Drug Application Announcement Connect Biopharma Holdings Limited, a biopharmaceutical company known for its unique care for the treatment of inflammatory disease, has proudly announced that its partner company, and a China-licensed comp...
Inventiva Announced a New Member for the Company Image Credits: The Pharma Letter Announcement Inventiva, a biopharmaceutical company known for the development of oral therapies mainly for the treatment of metabolic dysfunction-associated steatohepatitis (MASH), is happy to experience a transit...
Biocytogen and BeOne Medicines’ Licensing Agreement Image Credits: Biocytogen Announcement Biocytogen [Pharmaceuticals Co., Ltd., a leading biotechnology company that excels in research and development of antibody-based drugs with its innovative technologies] has signed a licensing agreem...
The Proposed Public Offering of Rhythm’s Image Credits: AInvest Announcement Rhythm Pharmaceuticals Inc., a commercial-based biopharmaceutical company, has nearly improved the lives of rare neuroendocrine patients and has released the proposed public offering of $150 million of its common...
BioNxt Solutions' Overview of New Advancements in the Healthcare Market Image Credits: Irish Sun Announcement BioNxt Solutions Inc., a biopharmaceutical company known for its advanced drug-delivery technologies, has introduced a new advancement in the potential development, focusing on the chem...
Quanterix closed the acquisition of Akoya Biosciences Image Credits: BioPharma APAC Announcement Quanterix Corporation, a leading company with its core scientific discovery via an ultra-sensitive biomarker identifier, has completed its previous acquisition of Akoya Biosciences Inc., a leader in...
Six Biotech Companies’ Initiative to Shape the Evergreen Age Image Credits: Faster Capital Announcement The modern era, which is experiencing and adopting computational techniques and deep biological knowledge, expects a change in rejuvenating the concerned area, as aging has been a core ...
Cardio Diagnostics Partnered with AGEPHA Pharma Image Credits: Caristo Announcement Cardio Diagnostics Holdings Inc., a leading cardiovascular medicine company, along with its advanced technology related to AI and intersecting epigenetics, has signed an agreement with AGEPHA Pharma. The agreeme...
Invivoscribe’s Support to CERo Therapeutics Image: News Hub Medianet Announcement Invivoscribe Inc., a leader in measurable residual disease (MRD) testing and accurate diagnostics, is joining hands with and appreciating CERo Therapeutics Holdings Inc.’s approach to innovative immuno...
Belay Diagnostics Evaluation Received the Green Signal Image Credits: Nature Announcement Belay Diagnostics, a CAP/CLIA Laboratory known for its commercialization and development of molecular diagnostics, mainly focusing on central nervous system (CNS) cancers, has confirmed the analytical vali...
Chugai and Gero Signed a License and Joint Research Agreement Image Credits: BioPharma BoardRoom Announcement Chugia Pharmaceutical Co., Ltd. and Gero PTE.LTD both a Singapore-based biotechnology company, has signed a licensed and joint research agreement to develop and introduce therapies for ...
Celltrion’s New Launch of Medication in the US Image Credits: Chosunbiz Announcement Celltrion USA confirmed that OSENVELT (denosumab-bmwo) and STOBOCLO (denosumab-bmwo), references to XGEVA and PROLIA, are available in the US. Access to these medications will improve and enhance patient ...
AI and Genetics: A New Hope for Pharma Companies Image Credits: Allerin Current Situation The pharmaceutical industry is facing difficulties in gaining the public's trust. The drug reactions often cause adverse effects to health and are not suitable for every individual. The advancement and dev...
Nasal COVID-19 Vaccine Demonstrates Positive Results in Phase 1 Clinical Trial Image Credits: NBC News Findings During the extreme stage of the COVID-19 pandemic, scientists noted that the complications of this infection started to increase severely with the SARS-CoV-2 virus entering the nasal ...
Onco-Innovations and Nucro-techniques Partnership to Elevate Human Trials Image Credits: WIVB Announcement Onco-Innovations Limited has signed an agreement with Nucro-technics Inc. on 3rd July 2025. Through this agreement, Nucro-Technics will organize a vast range of preclinical studies contrib...
Drug Development and Real-world Clinical Needs Establish a New Era in Oncology Image Credits: MEDSIR Concern The United States, till now, has completed 321.4% of phase 2/3 clinical trials. The percentage is less than compared of other regions' clinical trials. The patient recruitment and protoc...
Fresenius Medical Care and CCINSHAE's Strategic Collaboration to Expand Innovative Therapy Image Credits: Fresenius Medical Care Announcement Fresenius Medical Care, a global provider of products and services for patients suffering from renal diseases, will expand high-volume hemodiafiltration ...
Innocare’s Received Approval for a Clinical Trial in China Image Credits: BioWorld Announcement Innocare Pharma, a global biopharmaceutical company known for its advanced treatment for autoimmune diseases and cancer, received approval of an IND Investigational New Drug by the CDE Center f...
Brii Biosciences Signed a Licensing Agreement with Joincare Group Image Credits: Vietnam Investment Review Announcement Brii Biosciences, a global biotechnology company known for its excellent therapies for various diseases, has signed a technology transfer and license agreement with Joincare P...
Monte Rosa’s Solution in the Research Article Image Credits: Monte Rosa Therapeutics Inc. Publication Monte Rosa Therapeutics Inc., a global biotechnology company that has discovered molecular glue degrader (MGD) based medicines, introduced discoveries via a research article, featured on ...
Japan’s 3D Bioprinted Human Tissu e Market is Seeking Growth by 2025-2032 Current Status Japan’s 3D Bioprinted Human Tissue Market is concentrating on opportunities and growth in the coming years. The mid-year is focusing on innovation, development, and new engagement in this market t...
SurgiBox Partnered with Ondatec Medical Announcement SurgiBox Inc., a leading medical technology company known for its excellent surgical services, has entered into a partnership agreement with Ondatec Medical, a popular medical device provider in Turkey. This partnership strongly ref...
Pelthos Therapeutics Finalized the Merger Agreement with Channel Therapeutics Announcement Pelthos Therapeutics Inc., a global biopharmaceutical company known for marketing innovative therapeutic products for patients in need, is wrapping up the previous merger agreement with CHRO Merger Sub Inc...
Lixte Biotechnology Holdings Inc.'s Finalization of Securities in the Market Announcement Lixte Biotechnology Holdings, Inc., a pharmaceutical company, closed its private placement with valuable investors for the sale and purchase of $5.0 million of shares of common stock, a series B convertible...
Bluebird, a Center of Attraction What makes a popular equity firm approach a small biopharma firm? The Carlyle Group, along with SK Capital partner, intends to buy bluebird Bio for under $50 million. The Carlyle Group, with its $453 billion in assets under management, and SK Capital partner of $...
Which Company is Investing in Improving a Specific Treatment? Kardium Inc., a founder of the ‘Globe® Pulsed field system’, which is an innovative treatment for atrial fibrillation (AF), has increased its investment to US$250 million. The financing round consists of new investors s...
Gilead's Chances Peak Until GSK’s Response to the Competition Announcement Gilead’s new PreP drug, ‘Yeztugo’, is said to be reaching sales of $4.5 billion, if GSK doesn’t have anything to say about its Apretude medication. Gilead is strengthening its position in the...
BioVersys and Shionogi Joined Forces to Accelerate Research and Development Announcement BioVersys AG, a biopharmaceutical company known for its excellent research and development of antibacterial products for severe infections caused by multidrug-resistant (MDR) bacteria, has signed an exclusiv...
Rinri’s Clinical Trial Application, a First Approval of the Month Image Credits: Hearing Health & Technology Matters Announcement Rinri Therapeutics, a global company aiming to bring a transformation and development in sensorineural hearing loss (SNHL) with regenerative cell therapy, ...
Another Innovation to be Launched at ENDO 2025 Image Credits: The Manila Times Announcement Crinetics Pharmaceuticals, Inc. is ready to showcase eight abstracts from its clinical development programs, and its oral presentations involve an investigational drug candidate, atumelnant, and PALSONIF...
MaxCyte ExPERT Platform in Japan Image Credits: Galveston Country Daily News Announcement The PHC corporation, a biomedical division subsidiary of PHC Holdings Corporation, has entered an agreement with MaxCyte Inc. for the distribution of the MaxCyte ExPERT platform in Japan. In June, Singapor...
A Clinical Collaboration to Fuel the Healthcare Market Image Credits: Seeking Alpha Announcement Summit Therapeutics Inc., a biopharmaceutical oncology company, and Revolution Medicines Inc., a leading clinical oncology company, have entered into a clinical collaboration. Revolution medicines m...
HUTCHMED Received Approval from China Image Credits: Sharecast Announcement HUTCHMED (China) Limited has received approval from the China National Medical Products Administration (NMPA) for its new drug application merging TAGRISSO® (osimertinib) and ORPATHYS® (savolitinib). The approva...
Riliprubart Received Orphan Drug Designation in Japan Image Credits: Western Slope Now Announcement The Japanese Ministry of Health, Labour and Welfare appointed riliprubart as an orphan drug designation. Riliprubart is a monoclonal antibody suppressing active C1s in the classical complement fo...
ESTEVE’s Agreement with Sanofi Image Credits: AInvest Announcement ESTEVE signed an agreement with Sanofi, a French multinational pharmaceutical and health-care company, to acquire Caprelsa® (vandetanib) rights in over 50 countries and more. It’s a treatment that applies to chil...
June Wrap-up with Approvals Image Credits: Biospace Approvals The FDA recently granted approvals for UroGen and RSV immunization. With the approval, Moderna expands mRNA RSV shot. On 13th June 2025, the FDA confirmed Moderna’s mRNA vaccine, mResvia, for respiratory syncytial virus, a solu...
Orphalan Partners to Donate and Ensure Access to all Communities Image Credits: Wilson Disease Org Announcement Orphalan SA, a pharmaceutical company targeting rare diseases, announced its partnership with MAP International and the Wilson Disease Association (WDA). This alliance will enable acc...
FUJIFILM VisualSonics’ Smart Patform for Preclinical Ultrasound Image Credits: Imaging Technology News Announcement FUJIFILM VisualSonics Inc., popular in photoacoustic imaging systems and ultra-high frequency ultrasound, launched the Vevo F2 LAZR-X20 photoacoustic imaging platform. It is...
Pendopharm® and Kalvista® Collaborate to Broaden Treatment in Canada Image Credits: AInvest Announcement Pendopharm®, a part of Pharmascience Inc., has signed a distribution agreement with Kalvista Pharmaceuticals Inc., a leading biopharmaceutical company known for its development i...
Orano Med’s Expansion in Texas Announcement Orano Group’s subsidiary, Orano Med, expanded its Research and Development center to Plano, Texas (US) the new center, inaugurated to provide facilities for preclinical research and the development of radiopharmaceuticals. The center will f...
Avvio’s Certification Marked a New Phase in Global Transformation Image Credits: Avvio Medical Announcement Avvio Medical Inc., a private medical device company focused on treating kidney stone diseases, has received an ISO 13485:2016 certification for its audit, introduced by BSI (Britis...
Evaxion’s New Vaccine Program Image Credits: University of Alberta Announcement Evaxion, a techbio company leading in the development of AI-Immunology powered vaccines, has introduced a new vaccine program that is an add-on to the R&D pipeline. The company is encouraged to introduce a...
Bavarian Nordic’s First of Two Clinical Trials Image Credits: MedWatch Announcement Bavarian Nordic has initiated the first of two clinical trials to contribute to the use and approval of the MVA-BN mpox/smallpox vaccine for pregnant or breastfeeding women and 2-year-old infants. Further,...
ProFound Therapeutics, in collaboration with Novartis Image Credits: PharmaLive Which New Collaboration is Currently Streaming in the Healthcare Market? ProFound Therapeutics company focused on the human proteome to discover new medicines for various diseases, has entered into a collaboration w...
Riliprubart is Designated as an Orphan Drug in the US Image Credits: Yahoo Finance Announcement The US Food and Drug Administration approved Rilpivirine, positioning it as an orphan drug designation. Rilipubart, an investigational treatment for antibody-mediated rejection (AMR) in solid organ t...
Recordati’s Agreement with Amarin Image Credits: Fierce Pharma Announcement Recordati, an international pharmaceutical company, signed a license and supply agreement with Amarin, a company known for the treatment of cardiovascular diseases. The agreement’s purpose is to present a ma...
Verastem Oncology’s oral KRAS G12D (ON/OFF) Inhibitor in the First Patient Image Credits: Stock Titan Announcement Verastem Oncology, a biopharmaceutical company known for introducing new medicines for patients suffering from cancer-related RAS/MAPK, has announced that the first patient h...
Emery and Fortrea Pharma’s Collaboration Image Credits: Stock Titan Announcement Fortrea pharma, a known contract research organization (CRO), entered into a collaboration with Emery pharma, an analytical and bioanalytical CRO. The collaboration is initiated to deliver testing services un...
Zambon Approval and Entry into China Image Credits: Farmacia Rubino Announcement A multinational chemical pharmaceutical company, Zambon, known for its innovative care and cure, has received approval from Chinese regulatory authorities. Zambon received approval due to its vigorous local clinica...
Susan G. Komen’s Investment in Breast Cancer Research Image Credits: Susan G Komen Announcement Susan G. Komen, a known breast cancer organization, has invested $10.8 million in new research that will accelerate innovation in science and deliver effective solutions to patients suffering f...
SpaceX’s Entry in Vietnam? Image Credits: The Economic Times Announcement SpaceX, an American space technology company, has planned an expansion in Vietnam, expecting an opportunity in the healthcare market of the region that is open to adopting a digital transformation. Director of enter...
Questions on FDA Conditions Image Credits: Biospace New Regulatory Pathway At Bio2025, rare diseases leaders Yale, Ultragenyx, and Amylyx raised a few questions on the new regulatory pathways introduced by Marty Makary, an FDA commissioner. The leaders also acknowledged the efforts and addition...
GE Healthcare’s Approach to the Latest Technological Advancement Image Credits: MedTech Spectrum Announcement This year, at the Society of Nuclear Medicine and Molecular Imaging annual meeting, GE Healthcare highlighted an innovative technological solution by presenting an advanced portfo...
CHMP’s Opinion on Sarclisa Image Credits: Pharmaceutical Technology Announcement The European Medicines Agency’s Committee for Medicinal Products for Human Use (CHMP) recommendation for the approval of Sarclisa, combining dexamethasone, bortezomib, and lenalidomide for the induction...
Zivo Bioscience Partnered with Animal Health Companies to Advance Poultry Image Credits: AInvest Announcement Zivo Bioscience, Inc., an agtech R&D and biotech company known for its nutritional products and development of therapeutic has partnered with a leading animal health company to inve...
Vertex and Ono Pharmaceutical Entered into an Agreement Image Credits: Biospectrum Asia Announcement Vertex and Ono Pharmaceutical have signed a license agreement to develop and market Povetacicept in South Korea and Japan. Povetacicept is a therapeutic for various serious B-cell-mediated disea...
Taiwan's Trade Show Introduced Smart Healthcare Image Credits: Techsauce Announcement The Taiwan External Trade Development Council held a medical trade show, Medical Taiwan 2025, which attracted 316 exhibitors from 14 countries. The show highlighted advanced technology products fueled by gover...
Superlab Suisse in Geneva by 2026 Image Credits: Manufacturing Chemist Announcement Superlab Suisse has officially announced its fourth Swiss laboratory facility opening at Campus Biotech in Geneva. The new facility will be inaugurated by January 2026. The location will provide a vast space for...
Regeneron and Sanofi Receive Approval for the Medication Image Credits: FirstWord Pharma Announcement Sanofi and Regeneron Pharmaceuticals, Inc. received approval for Dupixent (dupilumab), a medication for adults suffering from bullous pemphigoid (BP). The approval of this medication was based ...
MorningStar’s Test Reached California Image Credits: AInvest Announcement MorningStar Laboratories, LLC (MSL), a global developer of precision diagnostic tests that analyze clinical needs, is proud to announce the availability of the Smartvascular Dx test (PULS Cardiac test) to patients i...
Brenus Pharma and InSphero’s Presentation Presentation InSphero, a leader in 3D cell-based assay technologies, of Swiss and Brenus pharma, a French biotech known for its next-generation excellent immunotherapies, showcased data at the European Association for Cancer Research 2025 annual co...
Immuno Cure and PharmaJet Collaborate to Advance a Vaccine Image Credits: Biospace Announcement Immuno Cure Biotech is a clinical-stage biotechnology group located in the Hong Kong Science Park, is initiating a collaboration with PharmaJet to examine the immunogenicity and safety of HIV therape...
Aptevo Therapeutics Buys Shares According to Nasdaq Rules Image Credits: NBC4 Announcement Aptevo Therapeutics Inc. is a clinical-stage biotechnology company that develops novel immune-oncology therapeutics according to its proprietary ADAPTIR-FLEX and ADAPTIR platform technologies has declared...
QIAGEN and GENCURIX Partner to Digitize the Healthcare Sector Announcement QIAGEN and GENCURIX partnered to develop oncology assays to perform on the QIAcuityDx platform. A platform popular for its excellent performance in the digital PCR system has been initiated for clinical diagnostics. GENCU...
1Elevan Shifts its Development to Fishers, Indiana Image Credits: Pharmaceutical Outsourcing Announcement 1Elevan Biopharmaceuticals company has shifted from California to Fishers, Indiana. The company has proclaimed the new headquarters in the Fishers Life Sciences and Innovation Park. The rel...
Invivoscribe’s Subsidiary Received Approval Image Credits: Invivoscribe Announcement Invivoscribe proudly announced its subsidiary’s Laboratory for Personalized Molecular Medicine (LabPMM) approval from the New York State (NYS) for the NPM1 MRD assay. The approval of the subsidiary ...
Leading Pharmaceutical Companies and their Competitive Negotiations Emerging Negotiations and Bids The acquisition of the company with the highest bid demonstrates the eagerness of the company for a merger, collaboration, and the unification and exchange of developmental progress between the two...
Standard Health and Smith+Nephew Announced a Partnership Image Credits: Orthopedic Design and Technology Announcement Smith+Nephew, a leading medical technology company, declared its partnership with Standard Health (www.standardhealth.co.uk). This partnership contributes to the development of ...
Noetik and Agenus's Collaboration for Technological Development Announcement Noetik, a global AI-driven spatial and multimodal biology, and Agenus Inc., an immune-oncology innovation, introduced a research collaboration to generate predictive biomarkers of response to Agenus. This will lead to b...
Johnson & Johnson Introduced Innovation in Various Regions Image Credits: Glance by Eyes on Eyecare Announcement Johnson & Johnson, a popular and leading company in eye health, declared an expansion of the portfolio of presbyopia-correcting intraocular lenses with the introduction of th...
Centessa Pharmaceuticals Received US FDA Clearance Image Credits: Seeking Alpha Approval Centessa Pharmaceuticals Plc, a clinical-stage pharmaceutical company, received a US Food and Drug Administration (FDA) IND clearance to initiate a phase 1 clinical study of ORX142 in healthy volunteers. Th...
Emerging Biopharma Deals Attract Analysts’ Interest in the Return of M&A Image Credits: Biopharma Dive Impact of Acquisitions and Deals The massive deals have generated analyst interest and support for activities in the second half of 2024, as the first half represents the cumulative ...
Advancements in Technology within the Pharmaceutical Industry Image Credits: Forbes Technology is an advancement in various markets and is being accepted in new and existing industries. The pharmaceutical sector is also adopting the modern era of technology and accelerating its computational pow...
HELP Therapeutics and China Resources Sanjiu’s Partnership Image Credits: Biopharma APAC Announcement HELP Therapeutics, a regenerative medicine leader, and China’s largest China Resources Sanjiu Pharmaceutical company have partnered to commercialize and co-develop the investigation...
Taipei City Government’s Partnership with Six Biotech Companies Image Credits: Biospace Announcement Taipei City Government will be announcing its partnership at the BIO International Convention (BIO2025) at the annual biotech event, which will be held Boston Convention & Exhibition C...
The EU’s Clinical Trial Market Aims to Seize the Opportunity Image Credits: Biospace Opportunity Europe’s contribution to the global clinical trial has been less over the last decade. With the change in the regulatory environment and research funding in the US, Europe could see an o...
Utilizing Technology for a Strengthened Healthcare System: Naga Malladi’s Predictive Breakthrough Analysis Image Credits: Oneindia Naga Srirama Narasimha Raviteja Malladi launched a transformative healthcare predictive analytics system capable of handling patient demands along with increas...
Chhattisgarh Signs MoU to Align Healthcare Services with Global Standards Image Credits: Times of India Chhattisgarh government signed a MoU with five powerful national and international institutions to improve the state’s healthcare system and improve overall state’s healthcare deli...
14-year-old Siddharth Develops an AI App to Detect Heart Disease in 7 Seconds Image Credits: Times of India Siddharth Nandyala, a 14-year-old boy from Frisco, United States, has developed a smartphone application which is capable of detecting in just 7 seconds. The application is named ‘Ci...
Aster DM Raises 1,900 Crore INR to Expand its Healthcare Presence Image Credits: Times of India Aster DM Healthcare, a leading Indian hospital network, raised Rs 1900 crore for expanding its hospital network across the country. The company has invested the money to establish its total bed capaci...
BioNTech and CureVac’s Purchase Agreement Image Credits: France 24 Announcement BioNTech and CureVac confirmed their entry in the official purchase agreement. Considering this agreement, BioNTech plans to acquire all shares of CureVac. CureVac, a leading clinical-stage biotech company, is...
Enterome's Funding for Clinical Development Image Credits: The Pharma Letter Investment and Funding in a Clinical Trial Enterome, a leading clinical-stage company known for its high-scale development of Oncomimics immunotherapies for cancer, has raised $19 million in fresh new financing for the...
Rivanna’s Selection for the Medtech Innovator 2025 Accelerator Cohort Image Credits: Rivanna Medical Announcement Rivanna, a leading manufacturer and medical device innovator known for its imaging-based medical solutions, proudly announced its ticket to join the Medtech Innovator 2025 acc...
Stakeholders in West Africa’s Healthcare Management, Innovation and More Image Credits: The Sun Nigeria Initiatives Stakeholders approached for collaboration, innovation, and implementation of new ideas to elevate and transform West Africa’s healthcare management. Following the decl...
Curadev’s Strategic Collaboration Image Credits: KGET.com Announcement Curadev Pharma, Inc., a leading clinical-stage biotechnology company, along with Memorial Sloan Kettering Cancer Center (MSK), a global cancer research and treatment institution novel immune-oncology therapeutics expan...
FDA Leaders Support Gene Therapy at Roundtable Conference Image Credits: Biospace Gene Therapy Gene therapy holds a prominent approach in providing treatment for genetic disorders. The gene therapy includes correcting or replacing faulty genes with healthy ones. The regional analysis states Nor...
Ambiq’s Achievement in Healthcare Semiconductor Solutions Image Credits: Ambiq Semiconductor in the Healthcare Industry Semiconductors play a significant role in healthcare by providing advancement and development in technologies and the medical devices market. It is a major component for...
Sanofi’s Smart Strategic Deals Image Credits: The Wall Street Journal What Licensing Deals Encourage Sanofi to Contribute to the Healthcare Market? Sanofi, a multinational pharmaceutical and healthcare company, has a strong approach to ROFNs in its licensing deal. Vigil, a clinical-stage ...
FUJIFILM Healthcare Europe and IBEX’s Partnership Image Credits: FugiFilm Announcement FUJIFILM Healthcare Europe, a leading digital pathology software 1, and Ibex Medical Analytics, an AI-powered cancer diagnostics company in pathology, announced a partnership. The partnership will contr...
Zimmer Biomet Introduced Technology Image Credits: ET Now Announcement Zimmer Biomet, a leading medical technology company, launched orthopedic technologies in India. The company is known for its orthopedic products and solutions. The portfolio consists of the shoulder segment, spanning the hip...
Merck’s Latest Treatment Solution Announcement Merck’s a healthcare company known for its innovative health solutions with its vaccines, biologic therapies, and more. The company is uplifting the therapy standards in healthcare by introducing ‘enlicitide decanoate.’ The e...
Sanofi and Regeneron are Strengthening their Medication Profile Image Credits: The Dermatology Digest Progress Sanofi and Regeneron pharmaceutical companies are leading the way with their popular biologic Dupixent. These companies are strengthening their eczema efficacy profile. The biologic Du...
Blue Cross's Partnership Strategy to Expand the GBA Healthcare Sector Image Credits: Insurance Asia Alliance Blue Cross (Asia Pacific) Insurance's partnership with four healthcare centers and the hospital is paving the way for the expansion of the healthcare and insurance sector. The partnershi...
Baroda BNP Paribas MF Introduced a Healthcare and Wellness Fund Image Credits: Baroda BNP Paribas Announcement Baroda BNP Paribas Asset Management India has introduced a new thematic equity scheme. A scheme is known as ‘Baroda BNP Paribas health and wellness fund. This new fund offer is r...
An Advancement in Science and Technology, a Contribution to Vietnam’s Healthcare Sector Image Credits: Business Wire Event The leading pharmaceutical industries showcased public-private partnership and innovation at the Healthcare Innovation Forum 2025, which was co-hosted in Hanoi by the...
OPTIC and Mechanica Partnership to Initiate AI-driven Venture Announcement Mechanica, a venture creation firm, to advantage Optic’s Bioptic platform innovatively. The expanded strategic collaboration intends to discover next-generation biotechnology companies. The collaborative initiative ...
Alnylam’s Goal is to Expand Medication Image Credits: Biospace Announcement Alnylam received two FDA approvals for Sanofi’s Qfitlia in hemophilia A and B, and Amvuttra in transthyretin-mediated amyloidosis. The approval is a part of Alnylam, along with other companies. Companies suc...
‘Sarepta’ Transitional Shift to Gene Therapy Development Image Credits: Biospace Platform Technology The FDA announced Sarepta Therapeutics as the FDA’s first-ever publicly documented platform technology designation. A designation for a popular vector known as ‘rAAVrh74&...
Pharmaceutical Companies Enter a New Era of Acquisitions Announcement Sanofi, a leading healthcare and pharmaceutical company, received a badge as the biggest buyer with a major contribution to rare disease specialist blueprint medicines of 9.5 billion. Whereas, Bristol-Myers Squibb offered a me...
A Drug Compilation for Small-cell Lung Cancer Image Credits: Fierce Pharma Announcement The Jazz and Roche pharmaceuticals have introduced an upgraded phase 3 data of the combined medicines Zepzelca and Tecentriq. This solution is planning to win FDA approval as a drug cocktail for small-cell l...
Image Credit: Reuters Amgen’s Imdelltra drug minimizes the risk of death by 40% in comparison to chemotherapy, mainly for small-cell lung cancer patients. The drug will help cure these patients after their worst condition, after the initial round of chemotherapy. The phase 3 trial of 509 pa...
Image Credits: Tech360.tv Announcement The US Food and Drug Administration introduced its generative AI tool, Elsa. Elsa is launched to improve and enhance operations and scientific reviews. The proven successful result of ‘Elsa’ was when one of the FDA’s applications of a pote...
Image Credits: Human Rights Watch Announcement The US President Donald Trump’s administration on Tuesday mentioned the offer of emergency abortion in every hospital. In his democratic predecessor Joe Biden’s tenure, he issued guidance that emergency abortion was discussed and asked t...
Image Credits: Reuters Announcement The US President Donald Trump’s administration on Tuesday mentioned the offer of emergency abortion in every hospital. In his democratic predecessor Joe Biden’s tenure, he issued guidance that emergency abortion was discussed and asked to consider ...
Image Credits: National Acamedy of Medicine Action The need to take action and put control on HHGE was first addressed in 2019. When a Chinese researcher, He Jiankui, Ph.D., discovered that twin girls were born from embryos with the ‘He gene’ edited using CRISPR. The group of gene ed...
Initiatives The United States has a vast number of records of donations. The country has initiated the distribution of billions of dollars to various countries. The diversified and well-established factors expand in areas such as security funding and economic development. Being the largest donor, t...
Plan Zydus Lifesciences is all set to acquire US-based Agenus Inc. and enter the vast biologics CDMO market along with two California facilities. This idea will enhance and improve Zydus Biotech's footprint. It will strengthen its place in Sri Lanka and India’s oncology market with its immune...
Announcement The Federal Express Corporation is one of the leading express transportation companies. The company proudly announced that the company’s hubs at Kansai International Airport, Japan (KIX) and Guangzhou Baiyun International Airport, China (CAN) have received the award and CEIV phar...
Initiative An effective collaboration gathered private sector partners to discover solutions. To promote solutions for cognitive health, a program was conducted on May 21-22, where two of Houston’s largest industry experts from the healthcare and energy sectors came together to highlight solu...
About Telehealth and Medicine Today is a platform for innovations, the latest research, digital health disciplines, telehealth, and applications in telemedicine. The open access to these factors accelerates the healthcare industry. The publication strengthens advancement and elevates discussion fol...
Announcement Blockchain in healthcare today is the first and single-reviewed journal representing blockchain and technologies to elevate the healthcare market. The BHTY announced the launch of its corporate advisory council. The launch is a valuable initiative to gather senior corporate leaders to ...
About The Perspectum is a popular medical technology company that provides digital technologies to support clinicians. The clinicians provide excellent care for patients suffering from multi-organ diseases, cancer, and chronic metabolic diseases with the help of technology. The company aims to impr...
Technological Advancement The known electronics manufacturer is creating smart hospital solutions with the use of NVIDIA technologies from the data center to the edge. The manufacturing of giant Foxconn will reduce the burden with the introduction of the new solution, ‘Nurabot’. The Nur...
New Technology A popular supply chain management solution provider, Tecsys Inc., launched a new technology, Tecsys IQ. It is a cloud-native intelligence layer that supports healthcare organizations by providing a unified fragmented data and AI-powered insights to financial, clinical, and operationa...
Announcement Bupa Hong Kong has announced its partnership with four leading premier healthcare providers named the GBA healthcare group, Prosper Health, Zhongshan Chen Xinghai Hospital, and Fosun Health. This partnership will give access to medical care in mainland China for residents of Hong Kong....
Date: 2nd June 2025 The Japanese subsidiary of a global cloud networking company, Engenius Networks Japan, will introduce the latest AI surveillance solutions and cloud-managed wi-fi 7 at Interop Tokyo 2025. It will be held at Makuhari Messe from 11th to 13th June. The event is a platform for digit...
Date: 2nd June 2025 Expansion Clarivate Plc is a global provider of transformative intelligence. The company announced the renewal of its multi-year partnership with CAPES. The extensional access to trusted Academia and Government Life Sciences and Healthcare data to over 400 Brazilian institution...
Date: 2nd June 2025 The Ujala Cygnus Group of Hospitals is initiating environmentally sustainable efforts by partnering with Karo Sambhav. This is India’s extended producer responsibility (EPR) and circular economy solutions provider. This strategic collaboration has introduced India’s ...
Date: 2nd June 2025 The International Healthcare Week 2025, Southeast Asia’s premier healthcare event, will be organized at the Malaysia International Trade and Exhibition Centre (MITEC), Kuala Lumpur, from 16 to 18 July. The event, initiated by Informa Markets, IHW 2025, aims to introduce in...
Date: 29th May 2025 Scope Health Inc., a leading eye-care company, announced its acquisition to support eye-care professionals. The acquisition is a valuable collaboration with the eye-care professionals is developing the finest ecosystem of products and leveraging service performance to enhance pa...
Date: 29th May 2025 Announcement Livanta, DOMA technologies, and Advanta government services are initiating to enter the transitional era of today’s healthcare market. With the ‘commence’ idea, the healthcare technology company has taken a step ahead to adopt human centered appro...
Date: 30th May 2025 Event The known provider of products and services for renal diseases, Fresenius Medical Care, showcased innovations and research at the 62nd congress of the European Renal Association. The event will be held on 4-7th June in Vienna, Austria. The event will introduce the company...
Date: 29th May 2025 Event Hong Kong’s International Medical and Healthcare 16th fair and the 5th Asia summit on global health (ASGH) were introduced by the Hongkong Kong Trade Development Council. The event was based on components of International Healthcare Week (IHW), Hong Kong. The event ...
Date: 29th May 2025 Hyperfine Inc. is the first health technology company to produce the world’s advanced FDA-cleared AI-powered portable MRI system for the brain. The ‘swoop system’ is a new technology officially introduced to the healthcare sector. This represents additional pro...
The global cosmetic chemicals market was valued at USD 24.91 billion in 2023. The market demand is anticipated to grow from USD 26.81 billion in 2024 to USD 41.7 billion by 2030, exhibiting a CAGR of 7.64% during the forecast period. The cosmetic chemicals market is the industry...
